Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
The END 7-OH Act would classify synthetic 7-hydroxymitragynine as a Schedule I controlled substance under federal law, placing it in the same legal category as drugs like heroin and LSD. The bill specifically targets synthetic versions of this chemical compound while explicitly exempting naturally occurring 7-hydroxymitragynine found in kratom, a plant whose leaves are commonly used in dietary supplements and traditional medicines. This legislation would affect manufacturers, distributors, and users of products containing synthetic 7-hydroxymitragynine, making possession and sale of these synthetic forms illegal under federal law. The bill does not specify funding or implementation timelines. The measure was introduced on March 19, 2026, and referred to the House Energy and Commerce Committee and Judiciary Committee for consideration.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.